Journal of Postgraduate Medicine, Education and Research

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  58 (2024)
Volume  57 (2023)
Volume  56 (2022)
Volume  55 (2021)
Volume  54 (2020)
Volume  53 (2019)
Volume  52 (2018)
Volume  51 (2017)
Volume  50 (2016)
Volume  49 (2015)
Volume  48 (2014)
Volume  47 (2013)
Volume  46 (2012)
Related articles

VOLUME 47 , ISSUE 4 ( October-December, 2013 ) > List of Articles

REVIEW ARTICLE

Recent Advances in the Diagnosis of Tuberculosis

Kusum Sharma, Suma B Appannanavar, Aman Sharma, Kapil Goyal

Citation Information : Sharma K, Appannanavar SB, Goyal K, Sharma A. Recent Advances in the Diagnosis of Tuberculosis. J Postgrad Med Edu Res 2013; 47 (4):181-187.

DOI: 10.5005/jp-journals-10028-1083

License: NA

Published Online: 01-12-2013

Copyright Statement:  NA


Abstract

How to cite this article

Sharma K, Appannanavar SB, Goyal K, Sharma A. Recent Advances in the Diagnosis of Tuberculosis. J Postgrad Med Edu Res 2013;47(4):181-187.

PDF Share
  1. Wkly Epidemiol Rec 2003;11;78(15):122-128.
  2. Diagnosis of tuberculosis. Indian J Pediatr 2000;67(2 Suppl):S3-8.
  3. Extrapulmonary tuberculosis. Indian J Med Res 2004;120(4):316-353.
  4. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr 2011;78(3):321-327.
  5. Extrapulmonary TB: what you need to know. Nurse Pract 2007;32(8):44-49.
  6. Multidrug-resistant tuberculosis. BMC Infect Dis 2008;8:10
  7. The TDR tuberculosis strain bank: a resource for basic science, tool development and diagnostic services. Int J Tuberc Lung Dis 2012;16(1):24-31.
  8. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis 2011; 64(4):265-71.
  9. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 2002;40(2):607-610.
  10. The Cy Scope(R) fluorescence microscope, a reliable tool for tuberculosis diagnosis in resource-limited settings. Am J Trop Med Hyg 2010;83(4):906-908.
  11. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6(9):570-581.
  12. Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosisendemic region. Int J Tuber Lung Dis 2011;15(4):483-488.
  13. Light emitting diodes for auramine O fluorescence microscopic screening of Mycobacterium tuberculosis. Int J Tuber Lung Dis 2006;10(9):1060-1062.
  14. Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J Med Microbiol 2009;27(3):217-221.
  15. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355(15):1539-50.
  16. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One 2009;4(12):e8341
  17. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2010;10(10):688-698.
  18. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Vietnam. BMC Infect Dis 2012;12:49
  19. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis. Indian J Med Microbiol 2012;30(1):64-68.
  20. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. J Microbiol Methods 2012;88(1):122-126.
  21. Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of Mycobacterium tuberculosis in smear-positive sputum. (Article in Chinese). Zhonghua Yu Fang Yi Xue Za Zhi 2011;45(1):21-25.
  22. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 2011;183(10):1427-1433.
  23. Reliability of the MODS assay decentralisation process in three health regions in Peru. Int J Tuber Lung Dis 2011;15(2):217-22.
  24. Utility of microscopic observation of drug susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuber 2010;57(4):207-212.
  25. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol 2010;48(12):4573-4579.
  26. Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol 2011;18(10):1616-1627.
  27. Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis 2001;20(10): 724-731.
  28. Direct detection of Mycobacterium tuberculosis in respiratory samples from patients in Scandinavia by polymerase chain reaction. Clin Microbiol Infect 1996;2(2):127-131.
  29. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007;45(6):1936-1940.
  30. Evaluation of a PCR assay for detection of Mycobacterium tuberculosis in clinical specimens. Diagn Microbiol Infect Dis 1995;22(4):357-360.
  31. Comparison of amplified Q beta replicase and PCR assays for detection of Mycobacterium tuberculosis. J Clin Microbiol 1995;33(4):860-867.
  32. Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium tuberculosis and other mycobacteria. Nucleic Acids Res 1994;22(13):2670-2677.
  33. Utility of polymerase chain reaction for detecting Mycobacterium tuberculosis in specimens from percutaneous transthoracic needle aspiration. Radiology 2002;225(1):205-209.
  34. Comparison of an internally controlled, largevolume light cycler assay for detection of Mycobacterium tuberculosis in clinical samples with the cobas amplicor assay. J Clin Microbiol 2005;43(4):1564-1569.
  35. Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR. J Clin Microbiol 2002; 40(11):4230-4234.
  36. Current issues on molecular and immunological diagnosis of tuberculosis. Yonsei Med J 2007;48(3):347-359.
  37. Evaluation of polymerase chain reaction using protein b primers for rapid diagnosis of tuberculous meningitis. Neurol India 2010;58(5):727-731.
  38. Multiplex PCR for rapid diagnosis of tuberculous meningitis. J Neurol 2011;258(10):1781-1787.
  39. Does multiplex polymerase chain reaction increase the diagnostic percentage in osteoarticular tuberculosis? A prospective evaluation of 80 cases. Int Orthop 2012;36(2):255-259.
  40. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthal Inflamm Infect 2013,3:25.
  41. Multiplex PCR for rapid diagnosis of gastrointestinal tuberculosis. J Global infect Dis (In press).
  42. Evaluation of multiplex PCR for rapid diagnosis of female genital tract tuberculosis. Indian J Med Sci (In press).
  43. Development of a new sensitive and efficient multiplex polymerase chain reaction (PCR) for identification and differentiation of different mycobacterial species. Trop Med Int Health 2003;8(2):150-157.
  44. PCR detection of coinfection with Mycobacterium tuberculosis and Mycobacterium avium in AIDS pateints with meningitis. J Med Microbiol 2012;61(Pt 12):1789-1791.
  45. Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients. J Med Microbiol 2008;57(Pt 4):439-443.
  46. Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis. Int J Tuber Lung Dis 2011;15(9):1211-1217.
  47. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363(11):1005-1015.
  48. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 2011;49(7):2540-2545.
  49. Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB). WHO Expert Group Report 2008:1-33. (Available at: http://www.who.int/tb/features_archive/expert_group_report_june08.pdf.
  50. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005;5:62
  51. Implementation of the INNO-Li PA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Int J Tuberc Lung Dis 2011;15(11):1546-1552.
  52. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis 2011 15(1):110-115.
  53. Molecular identification and characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis. Lett Appl Microbiol 2008;47(3):214-220.
  54. Multi-drug resistant tuberculosis and the red queen-diagnosis speed is crucial [Article in Portuguese]. Rev Port Pneumol 2007;13(6):869-877.
  55. Characterization of rpo B mutations by line probe assay in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from the aegean region in Turkey. Jpn J Infect Dis 2007;60(4):211-213.
  56. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif. TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol 2007; 45(9):3111-3114.
  57. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006;44(12):4384-4388.
  58. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006;12(5):752-759.
  59. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44(2):350-352.
  60. Direct application of the INNO-LiPA Rif. TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005;43(9):4880-4884.
  61. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003;41(9):4454-4456.
  62. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 2004;27(3):221-227.
  63. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J Med Res 2004;120(2):100-105.
  64. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J Med Res 2003;117:76-80.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.